INTRACEUTICS

Endoceutics, Inc.

Application Filed: 2016-11-22

Trademark Application Details

Status

601

Dead/Abandoned

ABANDONED - EXPRESS

Research	OneLook Acronym Finder
Serial Number	87245461
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Michael J. Leonard
Attorney Docket Number	114647.00051
Law Office Assigned	L40
Employee Name	MARTIN, CHRISTINE C

Timeline

2016-11-22	Application Filed
2017-03-06	Location: TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED
2017-06-30	Abandon
2017-07-03	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Endoceutics, Inc.
Address	2989, rue de la Promenade Quebec City, Quebe CA G1W2J5
Legal Entity Type	Corporation
Legal Entity State	CA

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

MICHAEL J. LEONARD
FOX ROTHSCHILD LLP
997 LENOX DRIVE, BLDG. 3
LAWRENCEVILLE, NJ 08648-2311

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	35
U.S. Codes:	100,101,102
International Codes:	40
U.S. Codes:	100,103,106
International Codes:	41
U.S. Codes:	100,101,107
International Codes:	42
U.S. Codes:	100,101

Type Code	Type
GS0051	Pharmaceutical preparations and substances for the prevention and treatment of menopause, sexual dysfunction, vaginal atrophy, decreased libido, gynaecological disorders affecting menstruation, premenstrual syndrome, sterility, menstrual syndromes, dysmenorrhea, infertility, genital tract infections, pelvic inflammatory diseases, endometriosis, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities; pharmaceutical preparations and substances for the prevention and treatment of menopausal problems, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, breast pain; pharmaceutical preparations and substances for the prevention and treatment of the endocrine system; pharmaceutical preparations and substances for the prevention and treatment of oily skin, acne, male baldness; pharmaceutical preparations and substances for the prevention and treatment of prostate cancer and benign prostate enlargement; pharmaceutical preparations and substances for the prevention and treatment of obesity, high cholesterol, diabetes, loss of muscle mass and strength, bone loss

Type Code

Type

GS0051

Pharmaceutical preparations and substances for the prevention and treatment of menopause, sexual dysfunction, vaginal atrophy, decreased libido, gynaecological disorders affecting menstruation, premenstrual syndrome, sterility, menstrual syndromes, dysmenorrhea, infertility, genital tract infections, pelvic inflammatory diseases, endometriosis, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities; pharmaceutical preparations and substances for the prevention and treatment of menopausal problems, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, breast pain; pharmaceutical preparations and substances for the prevention and treatment of the endocrine system; pharmaceutical preparations and substances for the prevention and treatment of oily skin, acne, male baldness; pharmaceutical preparations and substances for the prevention and treatment of prostate cancer and benign prostate enlargement; pharmaceutical preparations and substances for the prevention and treatment of obesity, high cholesterol, diabetes, loss of muscle mass and strength, bone loss

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2016-11-25	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2016-11-30	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2017-02-28	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2017-03-06	4 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2017-03-06	5 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2017-03-06	6 GNRN O:Outgoing Correspondence
TEAS EXPRESS ABANDONMENT RECEIVED	2017-06-30	7 EXAR I:Incoming Correspondence
ABANDONMENT - EXPRESS MAILED	2017-07-03	8 ABN1 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT	2017-07-03	9 MAB1 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.